跳至主要内容
临床试验/JPRN-UMIN000016769
JPRN-UMIN000016769招募中4 期

A prospective and retrospective multicenter cohort study of Daclatasvir + Asunaprevir combination therapy for chronic hepatitis C with and without liver cirrhosis - SMART-C V3

The University of Tokyo Hospital Department of Gastroenterology0 个研究点目标入组 1,000 人开始时间: 2015年3月11日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
The University of Tokyo Hospital Department of Gastroenterology

相似试验

已完成
不适用
A prospective and retrospective multicenter cohort study of hepatocellular carcionoma development in patients after hepatitis C virus eradicatioPatients after eradication of hepatitis C virus
JPRN-UMIN000023997Department of Gastroenterology, Graduate School of Medicine, the University ofTokyo2,000
招募中
Unknown
A study of Chlamydia trachomatis infection and reinfection in young adultsBacterial Infection
ACTRN12624000274572Sanofi Pasteur Inc.200
进行中(未招募)
不适用
A Prospective, Multi-center, Longitudinal Cohort Study of Dermagraft® in Subjects with Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial - Dermagraft® in Venous Leg Ulcers (DEVO Follow up)
EUCTR2010-019887-35-DEAdvanced BioHealing Inc180
进行中(未招募)
1 期
A Prospective, Multi-center, Longitudinal Cohort Study of Dermagraft® in Subjects with Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial - Dermagraft® in Venous Leg Ulcers (DEVO Follow up)Venous leg ulcersMedDRA version: 9.1 Level: LLT Classification code 10024134 Term: Leg ulcer (exc varicose)
EUCTR2010-019887-35-GBAdvanced BioHealing Inc180
进行中(未招募)
不适用
A Prospective, Multi-center, Longitudinal Cohort Study of Dermagraft® in Subjects with Venous LegUlcers: A Long-term Follow-up to the DEVO-Trial - Dermagraft® in Venous Leg Ulcers (DEVO Follow up)Venous leg ulcersMedDRA version: 14.1Level: LLTClassification code 10024134Term: Leg ulcer (exc varicose)System Organ Class: 10040785 - Skin and subcutaneous tissue disorders
EUCTR2010-019887-35-EEShire Regenerative Medicine, Inc.180